Laxmi Organic Industries Limited share price
NSE: LXCHEM · ISIN INE576O01020
Key numbers
- Market cap
- ₹ 5,042 Cr
- Current price
- ₹ 181.42
- 52-week high / low
- ₹ 217 / 108
- Stock P/E
- 40.0
- Book value
- ₹ 71.6
- Dividend yield
- 0.17%
- ROCE
- 4.7%
- ROE
- 4.1%
- Debt to equity
- 0.27
- Sales growth (3 yrs)
- -0.2%
- Profit growth (3 yrs)
- -14.0%
- 1-year return
- -14.0%
About Laxmi Organic Industries Limited
Laxmi Organic Industries Limited, together with its subsidiaries, manufactures and trades acetyl intermediates and specialty chemicals in India and internationally. The company offers essential products, such as ethyl acetate, acetaldehyde, acetic anhydride, n-propyl acetate, n-butyl acetate, and other proprietary solvents; and specialty products, such as ketene and diketene derivatives, fluorospeciality intermediates, esters, amides, arylides, and various specialties chemicals. It serves various sectors, including pharmaceuticals, packaging, agrochemicals, dyes, paints and coatings, flame retardants and thermal fluids, electronics, automobiles and semiconductors, fragrances and flavours, and electrical equipment, as well as coating, adhesives, sealants, and elastomers. The company also exports its products. The company was incorporated in 1989 and is based in Mumbai, India. Laxmi Organic Industries Limited is a subsidiary of Yellow Stone Trust.
Quarterly results
Consolidated figures in ₹ crores
| Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 710 | 693 | 719 | 735 | 968 |
| Operating profit | 59 | 31 | 50 | 54 | 114 |
| Net profit | 22 | 21 | 25 | 22 | 68 |
| EPS (₹) | 0.79 | 0.77 | 0.92 | -0.77 | 2.44 |
Concall summary (2026-08-04)
AI summary of the earnings call transcript · tone: Positive · source document
Guidance & outlook
- Against the backdrop of continued volatility arising from all these geopolitical uncertainties and the West Asia crisis, we have delivered a strong broad -based performance in quarter 1 FY27.
- And as we are navigating this, we expect that this will normalize over time.
Growth & demand
- Revenue for the quarter stood at INR9,683 million, growing 40% year -on-year and 32% sequentially, which is mainly driven by mix of volume growth and the higher price realization, as Rajan talks about.
- The EBITDA for the quarter was INR1,143 million, representing a growth of 272% year- on-year and 113% sequentially.
Margins & costs
- In addition to better pricing, our supply chain agility and procurement efficiencies contributed significantly to the growth in operating profitability during this quarter despite there were very big challenges on the increased freight side and the energy cost linked to tariffs and the coal prices.
- So we were at low single-digit EBITDA, and we have now seen high double -digit EBITDA, at least 11% to 12%.
Capex & expansion
- As Rajan talked about Dahej project, with the Dahej capex cycle nearing completion, our term debt has peaked at approximately around INR6,100 million, and we continue to maintain a healthy net debt equity of around 0.3x.
- Second, the entire INR600 crores plus gross CWIP plus the remaining capex will get capitalized in quarter 2.
Balance sheet & cash
- And that is something that Laxmi prides itself on and that is what we have basically leveraged.
- During this quarter, to secure the procurement efficiencies and ensuring the timely availability of the key raw materials in this volatile situation, our net working capital increased a bit during the quarter.
Peers in Specialty Chemicals
Data for information only, not investment advice. Prices end of day.